Lianyun Li

4.3k total citations · 1 hit paper
54 papers, 3.4k citations indexed

About

Lianyun Li is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Lianyun Li has authored 54 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 18 papers in Cancer Research and 16 papers in Immunology. Recurrent topics in Lianyun Li's work include Epigenetics and DNA Methylation (16 papers), RNA modifications and cancer (13 papers) and Genomics and Chromatin Dynamics (11 papers). Lianyun Li is often cited by papers focused on Epigenetics and DNA Methylation (16 papers), RNA modifications and cancer (13 papers) and Genomics and Chromatin Dynamics (11 papers). Lianyun Li collaborates with scholars based in China and United States. Lianyun Li's co-authors include Hong‐Bing Shu, Liang‐Guo Xu, Zhonghe Zhai, Ke-Jun Han, Yan‐Yi Wang, Yihong Ye, Qiuyan Wang, Min Wu, Mei Ye and Nia Soetandyo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Lianyun Li

52 papers receiving 3.4k citations

Hit Papers

VISA Is an Adapter Protein Required for Virus-Triggered I... 2005 2026 2012 2019 2005 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianyun Li China 26 1.9k 1.9k 657 558 418 54 3.4k
Sha-Mei Liao United States 10 1.5k 0.8× 2.0k 1.1× 563 0.9× 364 0.7× 486 1.2× 18 3.2k
Liang‐Guo Xu China 29 2.1k 1.1× 3.0k 1.6× 1.0k 1.6× 1.0k 1.8× 695 1.7× 63 5.1k
Fajian Hou China 19 1.8k 1.0× 1.8k 0.9× 265 0.4× 391 0.7× 296 0.7× 44 2.9k
Xiaomo Jiang United States 17 2.1k 1.1× 1.7k 0.9× 679 1.0× 346 0.6× 691 1.7× 19 3.3k
Beichu Guo United States 22 1.2k 0.6× 2.4k 1.3× 685 1.0× 381 0.7× 639 1.5× 28 3.4k
Brian Zarnegar United States 26 2.4k 1.2× 2.2k 1.2× 1.4k 2.2× 356 0.6× 705 1.7× 29 4.3k
Brian Skaug United States 14 1.4k 0.7× 1.4k 0.8× 525 0.8× 326 0.6× 292 0.7× 22 2.4k
Yaël Mamane Canada 21 1.7k 0.9× 1.7k 0.9× 496 0.8× 502 0.9× 939 2.2× 27 3.5k
Chris B. Moore United States 16 2.0k 1.0× 1.8k 1.0× 257 0.4× 594 1.1× 164 0.4× 20 3.1k
Kate L. Jeffrey United States 19 2.4k 1.3× 1.3k 0.7× 481 0.7× 268 0.5× 389 0.9× 33 3.7k

Countries citing papers authored by Lianyun Li

Since Specialization
Citations

This map shows the geographic impact of Lianyun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianyun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianyun Li more than expected).

Fields of papers citing papers by Lianyun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianyun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianyun Li. The network helps show where Lianyun Li may publish in the future.

Co-authorship network of co-authors of Lianyun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lianyun Li. A scholar is included among the top collaborators of Lianyun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianyun Li. Lianyun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Ming‐Liang, et al.. (2025). Identification of IL-34 and Slc7al as potential key regulators in MASLD progression through epigenomic profiling. Epigenomics. 17(5). 281–295. 1 indexed citations
3.
Wang, Chenyu, Qiaoyun Long, Zhuo Cao, et al.. (2024). The roles of nuclear orphan receptor NR2F6 in anti-viral innate immunity. PLoS Pathogens. 20(6). e1012271–e1012271. 1 indexed citations
4.
Lin, Xiang, Jidong Chen, Chen‐Yu Wang, et al.. (2023). Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer. Genome biology. 24(1). 268–268. 2 indexed citations
5.
Xiao, Qiong, Yong Xiao, Lianyun Li, Mingkai Chen, & Min Wu. (2022). Multifaceted regulation of enhancers in cancer. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1865(6). 194839–194839. 4 indexed citations
6.
Li, Qinglan, Xiang Lin, Yali Yu, et al.. (2021). Genome-wide profiling in colorectal cancer identifies PHF19 and TBC1D16 as oncogenic super enhancers. Nature Communications. 12(1). 6407–6407. 63 indexed citations
7.
Yu, Yali, Meng Chen, Hua Zhu, et al.. (2021). STAT1 epigenetically regulates LCP2 and TNFAIP2 by recruiting EP300 to contribute to the pathogenesis of inflammatory bowel disease. Clinical Epigenetics. 13(1). 127–127. 29 indexed citations
8.
Jiang, Lu, Chen‐Yu Wang, Lingao Ju, et al.. (2021). Histone demethylase LSD1 promotes RIG-I poly-ubiquitination and anti-viral gene expression. PLoS Pathogens. 17(9). e1009918–e1009918. 5 indexed citations
9.
Yao, Jie, Jihua Chen, Lianyun Li, & Min Wu. (2020). Epigenetic plasticity of enhancers in cancer. Transcription. 11(1). 26–36. 26 indexed citations
10.
Yao, Jie, Pin‐Ji Lei, Qinglan Li, et al.. (2020). GLIS2 promotes colorectal cancer through repressing enhancer activation. Oncogenesis. 9(5). 57–57. 22 indexed citations
11.
Chen, Meng, Qinglan Li, Nan Cao, et al.. (2019). Profiling of histone 3 lysine 27 acetylation reveals its role in a chronic DSS-induced colitis mouse model. Molecular Omics. 15(4). 296–307. 6 indexed citations
12.
Li, Qinglan, Lingao Ju, Jie Yao, et al.. (2019). The hyper-activation of transcriptional enhancers in breast cancer. Clinical Epigenetics. 11(1). 48–48. 47 indexed citations
13.
Ju, Lingao, et al.. (2018). Characterization of WDR20: A new regulator of the ERAD machinery. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(7). 970–980. 4 indexed citations
14.
Ju, Lingao, Yuan Zhu, Qiaoyun Long, et al.. (2018). SPOP suppresses prostate cancer through regulation of CYCLIN E1 stability. Cell Death and Differentiation. 26(6). 1156–1168. 39 indexed citations
15.
Wang, Zhen, Qiaoyun Long, Lin Chen, et al.. (2017). Inhibition of H3K4 demethylation induces autophagy in cancer cell lines. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1864(12). 2428–2437. 25 indexed citations
16.
Wang, Xiang, Lingao Ju, Jiadong Fan, et al.. (2014). Histone H3K4 methyltransferase Mll1 regulates protein glycosylation and tunicamycin-induced apoptosis through transcriptional regulation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(11). 2592–2602. 17 indexed citations
17.
Zhao, Quanyi, Jiadong Fan, Hong Wei, Lianyun Li, & Min Wu. (2012). Inhibition of cancer cell proliferation by 5-fluoro-2'-deoxycytidine, a DNA methylation inhibitor, through activation of DNA damage response pathway. SpringerPlus. 1(1). 65–65. 26 indexed citations
18.
Soetandyo, Nia, Qiuyan Wang, Yihong Ye, & Lianyun Li. (2010). Role of intramembrane charged residues in the quality control of unassembled T-cell receptor α-chains at the endoplasmic reticulum. Journal of Cell Science. 123(7). 1031–1038. 22 indexed citations
19.
Xu, Liang‐Guo, Yan‐Yi Wang, Ke-Jun Han, et al.. (2005). VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling. Molecular Cell. 19(6). 727–740. 1579 indexed citations breakdown →
20.
Li, Lianyun & Hong‐Bing Shu. (2001). Molecular mechanisms of TRAIL-induced apoptosis of cancer cells. Chinese Science Bulletin. 46(9). 707–708. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026